Does APIXABAN Cause Dyslipidaemia? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Dyslipidaemia have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
49
Reports of Dyslipidaemia with APIXABAN
0.0%
of all APIXABAN reports
3
Deaths
32
Hospitalizations
How Dangerous Is Dyslipidaemia From APIXABAN?
Of the 49 reports, 3 (6.1%) resulted in death, 32 (65.3%) required hospitalization, and 3 (6.1%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which APIXABAN Alternatives Have Lower Dyslipidaemia Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ